Marchetti Federica, Raju Suneil A, Nandi Nicoletta, Shiha Mohamed G, Cross Simon S, Rea Benjamin, Caio Giacomo, Sanders David S
Department of Translational Medicine, University of Ferrara, 44121 Ferrara, Italy.
Academic Unit of Gastroenterology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield S10 2JF, UK.
J Clin Med. 2024 Sep 12;13(18):5417. doi: 10.3390/jcm13185417.
: There is a paucity of data on mesenteric lymph node cavitation syndrome (MLNCS), a rare condition associated with coeliac disease (CD), characterized by central necrosis within enlarged mesenteric lymph nodes. The largest case series of MLNCS was completed in 1984, (n = 6) and a poor prognosis was identified. : A case series of all patients was conducted with MLNCS treated at the UK NHS England National Centre for Refractory Coeliac Disease between 2000 and 2023. A further literature review was conducted using PubMed and Google Scholar for patients with MLNCS and coeliac disease until 2023. : In total, there were 51 patients (6 from our case series and 45 from the literature review); 57% were female, and the mean age was 52.8 years (SD: 14.01 years). The most common presenting symptoms were weight loss (80%) and diarrhea (65%), and patients often had hyposplenism (80%). Persistent villous atrophy was present in 88% of the patients. Ten patients also had Refractory Coeliac Disease. Most of the patients (90%) were on a GFD, but the effect of this is unclear. Treatment with steroids and immunosuppressants resulted in a 40% survival rate. The overall mortality was 43%, associated with cachexia, sepsis, infectious complications, and lymphoma. : MLNCS has a poor prognosis, and its diagnosis should prompt further intervention and careful follow-up. Patients commonly present with weight loss and hyposplenism should prompt further investigation. Current treatment options are inadequate and novel therapies are required.
关于肠系膜淋巴结空洞综合征(MLNCS)的数据较少,这是一种与乳糜泻(CD)相关的罕见病症,其特征为肠系膜淋巴结肿大伴中央坏死。最大的MLNCS病例系列于1984年完成(n = 6),并发现预后不良。:对2000年至2023年在英国国民健康服务体系(NHS)英格兰国家难治性乳糜泻中心接受治疗的所有MLNCS患者进行了病例系列研究。使用PubMed和谷歌学术对截至2023年的MLNCS和乳糜泻患者进行了进一步的文献综述。:总共有51例患者(6例来自我们的病例系列,45例来自文献综述);57%为女性,平均年龄为52.8岁(标准差:14.01岁)。最常见的症状是体重减轻(80%)和腹泻(65%),患者常伴有脾功能减退(80%)。88%的患者存在持续性绒毛萎缩。10例患者还患有难治性乳糜泻。大多数患者(90%)采用无麸质饮食(GFD),但其效果尚不清楚。使用类固醇和免疫抑制剂治疗的生存率为40%。总死亡率为43%,与恶病质、败血症、感染性并发症和淋巴瘤有关。:MLNCS预后不良,其诊断应促使进一步干预和密切随访。出现体重减轻和脾功能减退的患者应促使进一步检查。目前的治疗选择不足,需要新的治疗方法。